The increasing recognition of non-fusion procedures for the spine
Preserving the inherent mobility of the spinal column is a significant milestone in the healthcare sector, steering away from the conventional approach of spinal fusion surgeries. Surgeons and medical innovators are actively developing devices that can be implanted to address various spinal conditions and injuries without resorting to fusion procedures. This innovative approach enables patients to retain a degree of flexibility and movement, a notable departure from the restricted mobility associated with fusion procedures. Among the array of treatments emerging in this domain, disc arthroplasty stands out as a widely adopted method, involving the replacement of a damaged disc with an artificial device designed to closely emulate the natural disc.
Recognizing the dynamic nature of the spinal column, healthcare professionals are increasingly embracing alternatives to traditional spinal fusion surgeries. The evolving landscape of medical technology and surgical innovations has led to the development of implantable devices that offer therapeutic solutions for diverse spinal conditions and injuries, all while avoiding the limitations imposed by fusion procedures.
Disc arthroplasty emerges as a prominent non-fusion treatment, gaining traction due to its effectiveness in addressing spinal issues. This procedure entails the substitution of a damaged disc with an artificial device meticulously crafted to replicate the characteristics of the natural disc. The primary advantage lies in the preservation of the patient's range of motion and flexibility, a departure from the immobilizing effects commonly associated with spinal fusion treatments. By mimicking the natural disc, disc arthroplasty not only addresses the underlying condition but also enhances the patient's overall quality of life.
The shift towards non-fusion procedures is underpinned by a desire to optimize patient outcomes and experiences. Retaining spinal mobility is crucial for maintaining a patient's daily activities and quality of life, making non-fusion procedures an attractive option for both medical professionals and those seeking spinal interventions. This paradigm shift aligns with the broader goals of healthcare industries to provide treatments that not only address the specific ailment but also prioritize the holistic well-being of the patient.
As awareness grows surrounding the benefits of non-fusion procedures, the healthcare sector is witnessing a paradigm shift in the approach to spinal interventions. Surgeons and medical engineers are at the forefront of this transformation, spearheading the development of innovative devices that offer effective solutions without compromising the natural mobility of the spine. The increasing adoption of treatments like disc arthroplasty signifies a positive stride towards a more patient-centric and nuanced approach to spinal healthcare. In the quest for improved outcomes and patient satisfaction, the trajectory of spinal interventions is veering towards non-fusion alternatives, marking a notable advancement in the field.
Slip Disc Market Size was valued at USD 8.5 Billion in 2023. The Global Slip Disc industry is projected to grow from USD 9.2 Billion in 2024 to USD 17.5 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% during the forecast period (2024 - 2032).
The herniated slipped disc is like a soft, cushion-like tissue that lies in between the spinal bones pushes out. The result of this can be quite painful as it presses the nerves and hurts them. A slipped disc is emerging as a common problem within the different population groups. The main symptoms of a slipped disc are constant pain, motor control loss, and much more. When the body develops a weak outer ring, it creates a situation where the inner portion slips out.
Nonactiveness and weak muscles also result in a slipped disc. People having obesity issues have a higher risk of acquiring a slipped disc problem as the disc has additional weight to support, as well. Due to lifestyle changes, people are procuring the slip disc problem that is acting as a blessing in disguise for the degenerative disc disease treatment market size.
COVID 19 Analysis
The slipped disc gives rise to spinal diseases that are inclusive of injuries related to the disc, nerves, spinal cord, and vertebrae. The spinal diseases can be identified as degenerative changes, spiel fractures and deformities, tumors, spondylolisthesis, and much more. The effects can range from mild to severe.
During the spread of the COVID 19 pandemic, the patient’s condition in both the spinal outpatient, as well as, the emergency department has crossed the critical stage and the level of seriousness is far from usual. The unfortunate times of the COVID 19 pandemic have also stipulated anxiety issues amongst individuals owing to the loneliness suffered in the pandemic.
The temperament of excessive worry about their health, illness, and contracting the coronavirus has increased hospital visits. The governments are investing in the infrastructure related to the slipped disc problems, along with the COVID 19 vaccine development to curb these issues.
The degenerative disc disease treatment market analysis picturized that the market is undergoing a major level of introduction, as well as, rapid adoption related to the technologically advanced medical devices. This is a considerable growth driver for the market. There is an increased quantum of investment being put forward by the manufacturers of medicines, drugs, and medical devices. Also, the research is extended to clinical trials, along with product launches to provide ease and better health with regards to slipped disc.
The slip disc treatment for the patients is a slow recovery mode but the end-result is reliable. However, if any individual wants to get the slip disc issues treated, the treatment cost is quite high. Also, there is a lack in the availability of medical professionals skilled in providing such treatments. These are the major restraints hampering the growth of the degenerative disc disease treatment market by the end of the future forecast year.
The slip disc market growth is witnessing a wide adoption of the medical equipment in the geriatric population chunk, increased support from the government sector, along increased expenditure for the development of the slip disc market. Also, the market is making use of the available technology for the development of new strategies. The expected result of this is the quick and wide adoption of therapies related to the treatment provided to people having slipped disc issues.
Key Findings
Slipped disc surgeries and other medical services are a part of the slip disc market. However, the market is a combination of different market segments. The degenerative disc disease treatment market segmentation is done on the following basis:
The market offers treatments to patients in the form of surgeries, therapies, as well as, proper medication, based on the condition of the problem.
The diagnosis of the slip disc problem among the patients is done based on imaging tests, conduction of nerve-related tests, as well as, physical examination.
The market segment of type includes cervical herniated discs, thoracic herniated, as well as, lumbar herniated disc tests of the patients suffering from slip disc issues.
The North American regions inclusive of the USA, and Canada, is expected to emerge as the market leader with a valuation of USD 4,542.8 million by the end of the global forecast period. The population of this region is witnessing a surge in spinal injury issues, which is leading the market growth. The Latin American market is witnessing a good growth graph. The lumbar herniated disc market precisely is expected to be the leading market sub-segment in Latin America.
The European nations are expected to emerge as the second largest in the market size. The research and development are expected to present the best result in the global market with a holding of 31%. The market has the presence of skilled professionals, advanced treatment facilities, and much more. The Asian Pacific market is expected to register a 6% CAGR growth by the end of the global forecast in 2023, owing to the rising awareness related to the slip disc issues. China is the largest player in the Asian Pacific market.
However, there is a major scope of improvement in the Middle East and African countries. The market needs to work on the creation of awareness amongst the population of the slip disc issues, and also, increase their accessibility and availability concerning the treatment facilities. Also, some low-income families cannot afford the diagnosis and treatment related to slip-disc issues.
Competitive Landscape
The slip disc treatment is possible because of the functioning of the key market players on the regional, and global level. The companies rendering their services for the degenerative disc disease treatment market growth are:
These companies are coming up with initiatives to help people transform their lives for a healthier tomorrow. Also, they are allocating budgets with government assistance for product portfolio development that helps in better treatment of the slip disc issues.
Recent Developments
Intended Audience
Report Overview
The slip disc recovery market report depicts the study conducted for a deep market analysis that is inclusive of both the quantitative and qualitative figures. These researchers have been conducted by the industry experts and their opinion has been taken into consideration to predict the future forecast growth by the end of the global forecast ending in 2032.
The historic and current market figures are also taken into consideration to notice the working of the key market players and draw a competitive landscape amongst them both on the regional, and global level. The report broadly analysis the performance of each market segment, sub-segment, and their growth prospects that will make a difference to the overall market valuation by the end of the global forecast year in 2032.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)